LABP   $0.304  32.62% Market Closed

Landos Biopharma Inc
Total Cash 29.00M
totalCashPerShare 9.279
EBITDA
Total Debt 0.00
quickRatio 4.302
currentRatio 4.434
Total Revenue
debtToEquity
Revenue/Share
ROA -0.39379
ROE -0.70672
grossProfits
freeCashflow -12.13M
operatingCashflow -20.80M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 42.67M
forwardPE -11.077295
floatShares 1.33M
sharesOutstanding 3.13M
sharesShort 1.43K
sharesShortPriorMonth 4.90K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.10%
heldPercentInstitutions 0.52%
Short Ratio help_outline 0.08%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 7.429
Price To Book help_outline 3.09
earningsQuarterlyGrowth
netIncomeToCommon -24.80M
trailingEps -4.00%
forwardEps -2.07%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.63 2Q 2024
institutionsCount 18
lastUpdated July 24, 2024, 9:04 a.m.